Written by Julia Rostova
President Donald Trump is heading to Beijing this week for a high-stakes summit with Chinese President Xi Jinping. While presidential visits to China are always market-moving events, the composition of Trump’s delegation makes this trip entirely unprecedented. He is bringing 16 of America’s most powerful corporate executives—a veritable “who’s who” of the U.S. economy, representing trillions of dollars in market capitalization.
The list of attendees includes Tesla CEO Elon Musk, Apple CEO Tim Cook, BlackRock CEO Larry Fink, and Boeing CEO Kelly Ortberg. Also on the manifest are the leaders of Goldman Sachs, Citigroup, Micron Technology, Qualcomm, Mastercard, and Visa. This is not a standard diplomatic mission; it is a transactional expedition. The agenda is expected to cover trade tariffs, artificial intelligence regulations, export controls, Taiwan, and the geopolitical fallout from the ongoing Iran conflict.
For investors, the summit represents the single largest geopolitical catalyst of 2026. The U.S.-China relationship has been defined by “de-risking” and decoupling for years, but this delegation suggests a potential pivot toward negotiated, pragmatic engagement. If deals are struck, the risk premium currently suffocating trade-exposed equities could evaporate overnight. Here is how to position your portfolio for the Beijing gambit.
The Aerospace Mega-Order
Perhaps the most immediately actionable storyline of the summit involves Boeing. The U.S. aerospace giant has been largely locked out of the lucrative Chinese commercial aviation market for years amid safety groundings and geopolitical retaliation. However, CEO Kelly Ortberg’s presence on the trip signals that a breakthrough may be imminent.
Reports from both U.S. and Chinese media suggest that China is considering a massive order for up to 600 Boeing jets. The package is rumored to include approximately 500 narrowbody 737 MAX aircraft and roughly 100 widebody jets, distributed across multiple state-owned Chinese airlines. This would be Boeing’s first major breakthrough in China in years and a critical component of any broader trade agreement, as aircraft purchases are the fastest way for Beijing to reduce its bilateral trade surplus with the United States.
Thesis on Boeing (BA) — BUY
The potential for a 600-jet mega-order makes Boeing a compelling buy ahead of the summit. The company already boasts a $695 billion backlog, but a massive commitment from China would validate its turnaround narrative and provide long-term revenue visibility. With the stock still recovering from historical lows, a headline-grabbing purchase agreement signed in Beijing could serve as the ultimate catalyst for a sustained rally.
The AI and Semiconductor Chessboard
Technology, specifically artificial intelligence and the semiconductors that power it, will be the most contentious topic on the agenda. The inclusion of Micron CEO Sanjay Mehrotra and Qualcomm CEO Cristiano Amon highlights the centrality of chip exports. Notably absent from the delegation is NVIDIA CEO Jensen Huang, who stated last week that it would be a “privilege” to attend if invited.
The U.S. has steadily tightened export controls on advanced AI chips and manufacturing equipment to China. In return, Beijing has restricted exports of critical rare earth minerals and pressured domestic firms to buy local silicon. The presence of Apple’s Tim Cook and Tesla’s Elon Musk—both of whom rely heavily on China for manufacturing and sales—underscores the delicate balance required. Apple faces declining iPhone sales in the region amid rising domestic competition, while Tesla needs regulatory approval to roll out its Full Self-Driving (FSD) software to Chinese consumers.
Thesis on Apple (AAPL) — HOLD
While Tim Cook is a master diplomat, Apple’s structural challenges in China cannot be solved by a single summit. The company is facing intense competition from domestic champions like Huawei, and consumer nationalism remains a headwind. A broader trade truce would certainly help sentiment, but until Apple demonstrates a clear stabilization of its market share in Greater China, the stock remains a hold.
The E-Commerce Wildcard
While the focus will be on the U.S. executives traveling to Beijing, the summit’s impact will be felt profoundly by Chinese equities listed in the United States. The geopolitical risk premium has kept valuations for Chinese tech giants artificially depressed for years.
Alibaba Group is arguably the most interesting play here. The e-commerce behemoth is scheduled to report earnings on Wednesday, May 13—the exact same time the summit is unfolding. Alibaba is aggressively pivoting toward artificial intelligence to revitalize its core business. The company is integrating its Qwen chatbot with Taobao and Tmall, enabling users to browse and purchase products through natural-language conversations. Furthermore, its AI Pay service recently exceeded 120 million transactions in a single week.
Thesis on Alibaba (BABA) — BUY
Alibaba presents a highly asymmetric risk-reward setup. The stock is trading at a depressed valuation relative to its historical averages and its U.S. peers. If the company delivers a solid earnings report demonstrating traction with its new AI commerce initiatives, and the Trump-Xi summit produces a de-escalation in trade rhetoric, Alibaba could see a violent short-squeeze and a rapid multiple expansion. The alignment of a major fundamental update with a massive geopolitical catalyst makes it a top pick for the week.
The Trump-Xi summit is not guaranteed to produce a comprehensive trade deal; the structural differences between the two superpowers are too vast for a quick fix. However, the sheer concentration of corporate power in the U.S. delegation suggests that transactional agreements are highly likely. Investors should position themselves in the companies best situated to benefit from a diplomatic thaw, particularly those where expectations—and valuations—remain stubbornly low.
────────────────────────────────────────────────────────────
Disclaimer: This article is for informational purposes only and does not constitute investment advice. The opinions expressed are those of the author and do not reflect the views of Equities Orbis or its affiliates. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
